DIRETRIZES SBD Diretrizes da Sociedade Brasileira de Diabetes DE Reprodução autorizada pela Sociedade Brasileira de Diabetes DIRETRIZES. Silva, F. M., Steemburgo, T., Azevedo, M.J., & Mello, V. D. (). sbdonline/ images/pdf/diabetes-tipo-1/Diretrizes-SBD-Alvos-pgpdf Sociedade. Data from patients were collected during the years and in a Diretrizes da Sociedade Brasileira de Diabetes – SBD
|Published (Last):||2 May 2008|
|PDF File Size:||15.55 Mb|
|ePub File Size:||5.98 Mb|
|Price:||Free* [*Free Regsitration Required]|
Diretrizes da Sociedade Brasileira de Diabetes | Rodrigo Damascena –
Enviado por Lorena Mayra flag Denunciar. Diabetes and car- diovascular disease: Diabetology and Metabolic Syndrome.
Efficacy of choleste- rollowering therapy in The effects of lowering LDL cholesterol with sta- tin therapy in people at dirretrizes risk of vascular disease: Heart Protection Study Collaborative Group: Heart Protection Study of cholesterol-lowering with simvastatin in 5, people with diabetes: Efficacy of Cholesterol-lowering therapy in people with diabetes in 14 randomised trials of statins: J Am Coll Cardiol Efficacy and safety of more intensive lowering of LDL cholesterol: Coronary artery calcium score prediction of all cause mor- tality and cardiovascular events in people with type 2 diabetes: A sys- tematic review and meta-analysis.
Associations bet- ween C-reactive protein, coro- nary artery calcium and cardiovas- cular events: Sociedade Brasileira de Direrrizes.
German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mel- litus undergoing hemodialysis.
N Engl J Med. Rosuvastatin and diretrrizes vascular events in patients under- going hemodialysis.
N Eng J Med. Effect of pravastatin on cardiovas- cular events in people with chro- nic kidney disease. Rosuvastatin in older patients with Systolic Heart Failure. Genfibrozil for the drietrizes preven- tion of coronary heart disease in men with low levels of high density lipo- protein cholesterol: Effects of long-term fenofibrate the- rapy on cardiovascular events in people with type 2 diabe- tes mellitus the FIELD study: Effects of combina- tion lipid therapy in type 2 diabe- tes mellitus N Engl J 0209.
Safety of treatment, changes in risk factors, and incidence of coro- nary heart disease. Secondary prevention by raising HDL dirwtrizes and reducing tri- glycerides in patients with coro- nary artery disease: Effects of fenofibrate treatment on cardiovascular disease risk in 9, individuals with type 2 diabetes and various components of the meta- bolic syndrome: Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
Sinvastatin with or without ezeti- mibe in familial hypercholesterole- mia.
The effects of lowering LDL choleste- rol with simvastatin plus ezetimibe in patients with chronic diretrizzes disease Study of Heart and Renal Protection: Terapia Nutricional das Dislipidemias. When to start choles- terol-lowering therapy in patients with coronary heart disease: